Versarian, Open Orphan (was Venn Life Sciences) and Russ Mould on 3 Stocks

Jun 28, 11:55 AM

Versarien discuss their first graphene order from a US based company. Open Orphan, previously Venn Life Sciences, explain their 4 legged strategy to achieve growth in the pharmaceutical services industry. Russ Mould talks about: Pressure Technologies, Morses Club & Marston’s.

On The Vox Markets Podcast Today: 28th June 2019

Neill Ricketts, Chief Executive Officer of Versarien #VRS discusses their first graphene order from a US based company and their New Head of US Operations.

Cathal Friel, Chief Executive Officer of Open Orphan #ORPH previously Venn Life Sciences, explain their 4 legged strategy to achieve growth in the pharmaceutical services industry.
(Interview starts at 14 minutes 34 seconds)

Russ Mould, Investment Director at stockbroker AJ Bell talks about: Pressure Technologies #PRES Morses Club #MCL Marston’s #MARS
(Interview starts at 28 minutes 10 seconds)

Plus the Top 5 Most Followed Companies & the Top 5 Most Liked RNS’s on Vox Markets in the last 24 hours.

Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.

#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast